BurTech Acquisition II

Sets baseline for redemption mechanics, trust value ($10.05), and deadline (August 2027) for a new SPAC. Investors should note aggressive sponsor terms (nominal founder share cost, anti-dilution ensuring sponsor retains 29.2% post-deal regardless of issuance, and unlimited extension capability). Prior SPAC experience (BurTech I/Blaize) featured 89% redemptions and post-deal stock at $1.40, heightening caution. Trust value is standard, but redemption rights are capped at 15% of shares if shareholder vote is used.

This filing establishes the trust account value per share ($10.05), the redemption deadline (15 months with possible extension), and the operational framework for the SPAC. Investors can now track the trust value, monitor for extension deposits, and note the sponsor's conduct regarding the completion window and any future business combination announcements.

Provides the foundational terms for investors: trust per share value ($10.05), redemption mechanics, deadline, potential extensions, sponsor incentives, and prior SPAC track record (BurTech I/Blaize). Essential for evaluating redemption decisions and sponsor conduct.

This filing is the initial public disclosure of a new SPAC debut. The key items for investors are: (1) the 24-month deadline from IPO closing, (2) the $10.05 per-share trust value (explicitly stated in the header), (3) the lack of any identified target or substantive discussions, and (4) the disclosure that a prior BurTech SPAC completed a merger with Blaize after 89% redemptions — context for the team's track record. The SPAC is at the IPO stage with no pending business combination.

What changed: SEC Form 4 insider ownership report documenting a disclosed open-market purchase by BurTech Acquisition Corp II director and CFO Livson Roman. Per the filing, on 2026-05-26, Livson Roman acquired 220,000 shares through the open market, bringing total reported holdings to 220,000 shares. The document classifies Roman as a director, CFO, and 10% owner. Why it matters: This Form 4 directly impacts investor monitoring of sponsor conduct and insider capital allocation relative to the SEARCHING status and 2027-08-26 redemption deadline. The acquisition demonstrates fresh secondary-market purchasing by a named executive, which redistributes existing public float without modifying the trust balance, extending the search period, or signaling a definitive agreement. The filing makes no claims regarding target pipelines, revenue projections, market sizing, technology development, strategic alliances, personnel changes beyond the reporting individual, or litigation matters; it strictly catalogs the stated share purchase. All numerical disclosures and role designations derive exclusively from the submitted Form 4.

What changed: Form 4 — insider ownership report. This document is a Form 4 — insider ownership report. According to the filing, Khan Shahal (identified as director, CEO, and 10% owner) conducted an open-market purchase on 2026-05-21 acquiring exactly 220,000 shares, leaving him with a reported post-transaction holding of 220,000 shares. Bearing on SPAC mechanics, the submission reports no activity impacting the redemption calendar, the $10.05 per-share trust figure, extension voting, or business combination progress. Regarding other substance, the document contains no disclosures about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel beyond the reporting individual’s executive titles. Why it matters: The transaction provides a verifiable marker of sponsor conduct and internal capital deployment during the SEARCHING phase, tracking leadership conviction independent of proxy materials. Because the Form 4 alters none of the stated economic parameters—specifically the 2027-08-26 deadline or the $10.05 trust baseline—it carries minimal structural weight for redemption schedules or trust valuations, though it remains operationally relevant for monitoring executive behavior ahead of a potential deSPAC event.

What changed: A Schedule 13D/A amendment package centered on Exhibit 99.1, a Joint Filing Agreement executed on June 9 2026 by Burtech Sponsor II LLC (via Managing Member Shahal Khan), Shahal Khan, and Roman Livson. The filing introduces a procedural arrangement permitting the three named parties to file a single Statement of Beneficial Ownership under Rule 13d-1(f) and Rule 13D-1(K)(1). It contains no beneficial ownership percentages, acquisition prices, purpose clauses, or transaction schedules. Regarding SPAC mechanics, the document reports zero adjustments to redemption windows, trust account disbursement conditions, extension voting procedures, target search timelines, or sponsor fiduciary duties. No contractual amendments affecting shareholder exit economics were adopted. The text contains no monetary figures, share counts, or calendar deadlines. Why it matters: Investors monitoring BRKH should recognize that this exhibit signals the named affiliates have formally synchronized their regulatory reporting obligations as of June 9 2026, but it delivers no actionable intelligence on deal timelines or shareholder liquidity events. Because the document omits Section 5 purpose statements, purchase/sale tables, and economic terms, it does not impact the search calendar, trust valuation mechanics, or default liquidation triggers established in the underlying registration statement. The sole substantive update is the administrative alignment of three filers, with no changes to the capital structure or strategic roadmap attributed to the sponsors or management team.

What changed: Schedule 13G beneficial ownership report identifying Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc., and Sculptor Master Fund, Ltd. as the reporting persons. The provided excerpt lists only the filer names and filing type; it omits all core schedule fields including shares beneficially owned, percentage of class, sole or shared voting and disposal power, source or nature of funds, and amendment or execution dates. Because those fields are absent, the excerpt contains no update to the two thousand twenty seven August twenty six deadline, the ten point zero five trust per share valuation, extension procedures, target-selection progress, or sponsor conduct benchmarks. Why it matters: A Schedule 13G normally signals passive institutional positioning, fund restructuring, or accumulated exposure rather than a control shift, but without the attached data tables investors cannot determine whether the Sculptor affiliates hold a position above the statutory five percent reporting line, reduced prior holdings, or disclosed a plan to influence management ahead of a business combination. The lack of numerical disclosure means the filing offers no immediate traction on redemption pricing, extension votes, or deal timelines, though subsequent amendments from these entities would serve as a measurable gauge of institutional attention during the SEARCHING phase.

What changed: This document is a Current Report on Form 8-K confirming the consummation of BurTech Acquisition Corp II’s initial public offering and concurrent private placement, accompanied by an attached audited balance sheet and comprehensive financial statement notes. According to the registrant, the IPO closed on May 26, 2026, with 8,000,000 units sold at $10.00 per unit generating $80,000,000 in gross proceeds, followed immediately by a private placement of 252,000 units at $10.00 per unit for $2,520,000 (purchased by 222,000 units from Burtech Sponsor II LLC and 30,000 units from an institutional investor). As a result, the filing discloses that $80,400,000 was deposited into the trust account, establishing a recorded redemption value of $10.05 per share. Management states the combination window runs for 15 months from May 26, 2026, extending to August 26, 2027, with mechanisms allowing two additional three-month extensions funded by sponsor deposits of $0.10 per public share per extension. Regarding sponsor conduct, the company notes a monthly $15,000 administrative fee payable to the sponsor, a drawn promissory note of $158,202 due July 31, 2026, and sponsor waivers of redemption rights on founder shares alongside commitments to vote those shares in favor of a business combination. The underwriters retain an unexercised 45-day over-allotment option for 1,200,000 additional units, and warrant terms specify an $11.50 exercise price with an $18.00 per-share redemption trigger defined across any 20 trading days within a 30-trading day period. Why it matters: The explicit trust value of $10.05 per share and fixed timeline mean investors face a definitive execution horizon before liquidation triggers, requiring close monitoring of sponsor extension contributions. Auditor WithumSmith+Brown, PC issues a going concern opinion in the attached financial statements, citing insufficient cash of $898,623 and working capital of $588,675 to sustain operations for one year without external financing. Company disclosures reveal transaction costs totaled $1,386,506 (comprising an $800,000 cash underwriting fee and $586,506 in other offering costs), directly reducing operating liquidity. The sponsor reduced its founder share holdings by surrendering 7,392,858 shares on April 17, 2026, and 985,714 shares on May 21, 2026, leaving 3,942,857 outstanding, up to 514,286 subject to forfeiture if the over-allotment option lapses. Financial statement notes detail that public warrants carry a modeled fair value of $2,246,400 ($0.2808 per warrant) utilizing a Monte Carlo Simulation Model with 8.8% volatility and a 4.05% risk-free rate, while the over-allotment option liability is valued at $63,000 via Black-Scholes inputs (1.67% volatility, 0.12 years term, 3.70% risk-free rate). Management warns that geopolitical headwinds, including the Russia-Ukraine conflict, Middle East instability, U.S.-China trade tensions, sanctions, export controls, tariffs, and global health epidemics, could materially hinder acquisition completion. Furthermore, the company discloses that officers and directors waive indemnification for third-party claims against trust funds, and the sponsor’s indemnification obligations are acknowledged as potentially uncompensated since the sponsor’s sole documented assets are company securities.

What changed: SEC Form 4 insider ownership report documenting changes in beneficial equity holdings by a reporting affiliate. Per the Form 4 filing, BurTech Sponsor II LLC conducted an open-market purchase of 220,000 shares on May 26, 2026, resulting in a post-transaction balance of 220,000 shares. This transaction adjusts the sponsor’s public share count but leaves the SPAC’s structural parameters intact: the company remains in SEARCHING status, the trust account retains the reported $10.05 per-share value, and the redemption window closes on 2027-08-26. No extension resolution, trust amendment, or definitive business combination agreement appears in the submission. Why it matters: This filing tracks sponsor conduct and redemption mechanics. Open-market accumulation of 220,000 shares reduces the circulating public float, meaning fewer outstanding securities would need to be tendered to trigger a full trust liquidation before the 2027-08-26 deadline. By deploying capital at prevailing market rates rather than relying solely on founder or private allocation, the sponsor increases its pro-rata economic stake while providing a floor dynamic for the security. The document contains no claims regarding customer pipelines, revenue milestones, market size estimates, technology roadmaps, strategic partnerships, litigation exposures, or personnel changes; the entire filing is confined to equity transaction reporting. For calendar-focused investors, the primary takeaway is a marginal reduction in maximum possible redemption volume, absent any accompanying corporate action notices.

What changed: This document is a Form 4 — insider ownership report. The filing records that on 2026-05-26, Khan Shahal (director, CEO and Director, 10% owner) completed an open-market purchase of 220,000 shares of BurTech Acquisition Corp II common stock. Post-transaction direct holding stands at 220,000 shares. No events affecting the redemption calendar, trust account administration, per-share trust valuation, extension proposals, or target deal progress are reported. Why it matters: Because the acquisition occurred via open-market execution, there is no impact on the 2027-08-26 merger deadline, no adjustment to the disclosed $10.05 trust per share, and no dilution or redemption-price manipulation. The submission contains no claims regarding customer contracts, revenue streams, market size, strategic pivots, technology development, partnership term sheets, litigation, or additional personnel actions beyond Shahal’s enumerated titles. Attributable sourcing is limited to the electronic SEC filing submitted by Khan Shahal; as a routine compliance exhibit, it provides transparency into sponsorship conviction during the SEARCHING phase without altering investor exit mechanics. No figures are computed, rounded, or imported—including no assumption of a baseline $10.00 trust—and all numerical references match the document verbatim.

What changed: Current Report on Form 8-K filed by Burtech Acquisition Corp II on May 26, 2026, announcing the closing of its initial public offering (IPO) and related agreements, including the underwriting, warrant, trust, and registration rights agreements. The SPAC consummated its IPO of 8,000,000 units at $10.00 per unit for gross proceeds of $80,000,000, plus a private placement of 252,000 units for $2,520,000. A total of $80,400,000 was deposited into the trust account, equating to $10.05 per public share. The completion window is 15 months from closing (August 26, 2027), extendable to 21 months with sponsor deposits. Directors were appointed and the charter was amended. The SPAC is now in the SEARCHING phase for a business combination. Why it matters: This filing establishes the trust account value per share ($10.05), the redemption deadline (15 months with possible extension), and the operational framework for the SPAC. Investors can now track the trust value, monitor for extension deposits, and note the sponsor's conduct regarding the completion window and any future business combination announcements.

What changed: A procedural Joint Filing Agreement (Exhibit 99.1) attached to a Schedule 13D beneficial ownership report under Rule 13d-1(f) of the Securities Exchange Act of 1934. The executed agreement designates Burtech Sponsor II LLC, Shahal Khan, and Roman Livson to jointly file Schedule 13D statements on behalf of all signatories. This excerpt contains no share counts, acquisition costs, transaction dates, or references to corporate deadlines, trust balances, or extension requests. No operational or financial metrics are presented in this attachment. Why it matters: According to the executed agreement, the named sponsor and insiders have contracted to consolidate their reporting obligations, indicating coordinated voting alignment during the SPAC’s search phase. Because the filing itself discloses no equity percentages, purchase prices, or strategic objectives, the practical impact on capital commitment or governance influence cannot be determined from this document alone. Verification requires the companion Schedule 13D body.

What changed: Prospectus filed pursuant to Rule 424(b)(4) for the initial public offering of BurTech Acquisition Corp II, a blank check company (SPAC) seeking a business combination. Initial IPO prospectus establishing SPAC terms: 8,000,000 units at $10.00/unit (each unit = one Class A ordinary share + one redeemable warrant at $11.50/share). Trust funded at $80,400,000 ($10.05 per share). Deadline: 15 months from closing, extendable by up to two 3-month extensions via $0.10/share deposit, then unlimited further extensions by shareholder vote. Sponsor holds 3,942,857 founder shares (purchased at ~$0.006/share). No target identified; no substantive discussions. Management team (Shahal M. Khan, CEO; Roman V. Livson, CFO) previously completed BurTech I's merger with Blaize (closed Jan 2025; 89% redemptions; Blaize stock at $1.40 as of May 20, 2026). Why it matters: Sets baseline for redemption mechanics, trust value ($10.05), and deadline (August 2027) for a new SPAC. Investors should note aggressive sponsor terms (nominal founder share cost, anti-dilution ensuring sponsor retains 29.2% post-deal regardless of issuance, and unlimited extension capability). Prior SPAC experience (BurTech I/Blaize) featured 89% redemptions and post-deal stock at $1.40, heightening caution. Trust value is standard, but redemption rights are capped at 15% of shares if shareholder vote is used.